Literature DB >> 7501543

Retinoblastoma gene mutations in primary human prostate cancer.

Y Kubota1, K Fujinami, H Uemura, Y Dobashi, H Miyamoto, Y Iwasaki, H Kitamura, T Shuin.   

Abstract

Structural alterations in the entire coding regions (exons 1 to 27) of the retinoblastoma (RB) gene in primary human prostate cancers were investigated, using polymerase chain reaction and single strand conformational polymorphism analysis of RNA. Of 25 samples obtained from patients, four (16.4%) were found to have RB alterations. DNA sequencing of the PCR products revealed point mutations resulting in single amino-acid substitutions of exons 6 and 19 in two cases, and base deletions of exons 8 and 17 in two cases. Two of four cases with RB mutations were moderately differentiated localized tumors and other two with RB mutations were poorly differentiated tumors with metastases. Our results suggest that RB gene mutation is involved in progression steps of prostate carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7501543     DOI: 10.1002/pros.2990270604

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

Review 1.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 2.  Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer.

Authors:  Ana Aparicio; Robert B Den; Karen E Knudsen
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

Review 3.  The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.

Authors:  Joanne N Davis; Mark L Day
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

4.  Rb1/105 gene alterations and head and neck carcinogenesis.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Ishrat Mahjabeen; Muhammad Saeed; Faraz Arshad Malik; Mahmood Akhtar Kayani
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

5.  The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.

Authors:  Sergiy I Borysov; Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

6.  Tumor suppression by a severely truncated species of retinoblastoma protein.

Authors:  Hong Yang; Bart O Williams; Phillip W Hinds; T Shane Shih; Tyler Jacks; Roderick T Bronson; David M Livingston
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 7.  Molecular biology of prostate cancer.

Authors:  X B Shi; P H Gumerlock; R W deVere White
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

8.  Synthetic lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a novel peptidyl prolyl isomerase gene.

Authors:  Kyle A Edgar; Marcia Belvin; Annette L Parks; Kellie Whittaker; Matt B Mahoney; Monique Nicoll; Christopher C Park; Christopher G Winter; Feng Chen; Kim Lickteig; Ferhad Ahmad; Hanife Esengil; Matthew V Lorenzi; Amanda Norton; Brent A Rupnow; Laleh Shayesteh; Mariano Tabios; Lynn M Young; Pamela M Carroll; Casey Kopczynski; Gregory D Plowman; Lori S Friedman; Helen L Francis-Lang
Journal:  Genetics       Date:  2005-03-02       Impact factor: 4.562

9.  Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers.

Authors:  Elisabet Ognedal Berge; Stian Knappskog; Stephanie Geisler; Vidar Staalesen; Marec Pacal; Anne-Lise Børresen-Dale; Pål Puntervoll; Johan Richard Lillehaug; Per Eystein Lønning
Journal:  Mol Cancer       Date:  2010-07-01       Impact factor: 27.401

10.  Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Kashif Ali; Ishrat Mahjabeen; Muhammad Saeed; Mahmood Akhtar Kayani
Journal:  Cell Oncol (Dordr)       Date:  2014-06-03       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.